Results 161 to 170 of about 399,478 (308)
Editorial: Dyslipidemia, prevention in the era of personalized medicine? [PDF]
Kallel A, Banach M.
europepmc +1 more source
A miniaturized drug sensitivity and resistance testing (DSRT) workflow based on the Droplet Microarray (DMA) platform enables functional drug testing using minimal patient‐derived tumor material. By screening nanoliter‐scale droplets containing as few as 300 cells, this approach generates reproducible and tumor‐specific drug response profiles ...
Maryam Salarian +7 more
wiley +1 more source
Central Sensitization in Spondyloarthritis: Implications for Personalized Medicine. [PDF]
Carli L +6 more
europepmc +1 more source
A human 3D bone niche integrating osteoblasts and osteoclasts enables co‐culture with prostate cancer cell lines and patient‐derived organoids. The engineered niche (i) models aspects of reciprocal phenotypic regulation between osteoblasts and cancer cells, (ii) captures osteoclast‐enhanced osteomimicry in tumor cells, and (iii) establishes a ...
Andrea Mazzoleni +7 more
wiley +1 more source
Personalized Medicine in Otolaryngology: Reflections on a Multidisciplinary Special Issue. [PDF]
Abouzari M.
europepmc +1 more source
ABSTRACT In vitro arterial models offer ethical and robust alternatives for vascular research but require cytocompatible materials that replicate physiological mechanics. Poly(vinyl alcohol) (PVA) hydrogels produced by directional freezing and salting‐out (PVA DFSO) are anisotropic yet lack stability for cell culture. Herein, methacrylated PVA (PVA‐MA)
Javiera Sanhueza Ortega +4 more
wiley +1 more source
P308: The scope of incorporating preemptive pharmacogenomics testing for public healthcare
Joy Sheng +3 more
doaj +1 more source
Is ANCA-Associated Vasculitis Ready for Personalized Medicine? [PDF]
Popa CA, Walsh M.
europepmc +1 more source

